SEC Form 4 · accession 0001104659-16-109933
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Sblendorio
Officer — EVP, COO & CFO, Treasurer
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $44.90 | Apr 1, 2016 | A | 150,000 | A | — | Mar 31, 2026 | Common Stock | 150,000 | 150,000 | D |
| Restricted Stock UnitsF2,F3 | — | Apr 1, 2016 | A | 75,000 | A | — | Mar 31, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This option was granted on April 1, 2016 and will vest over a four-year period, with 25% of the shares underlying the option vesting on April 1, 2017 and the remainder of the shares vesting in equal monthly amounts thereafter until April 2020, subject to continued service with Ophthotech Corporation.
- F2Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F3These restricted stock unit awards were granted on April 1, 2016 and will vest over a four-year period, with 25% of the shares underlying the restricted stock unit awards vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to continued service with Ophthotech Corporation.